Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

False Claims Act suit alleging that medical practices engaged in a scheme to overbill Medicare for Amgen Inc. drugs is now dismissed, a New York federal district court said.

In addition to Dr. Bachleda, members of the Eyconis Board of Directors include Dr. Cunningham, who serves as Executive Chair, Jan Mikkelsen, President & CEO of Ascendis Pharma A/S, Daniel Estes, Ph.D.

Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in ...

ALS, MS, post-traumatic brain injury? This biotech company has a target choice to make for an upcoming clinical trial — and ...

Amgen Inc. closed $13.93 short of its 52-week high ($346.85), which the company reached on July 25th.

The Congressional Black Caucus Foundation's Annual Legislative Conference panel on the Road to Health Equity discussed the ...

On June 28, 2024, the United States Patent and Trademark Office (“USPTO”) requested the public’s views on the current state ...

Researchers reported at the ESMO Congress that 78 percent of patients responded to front-line treatment with Lumakras, ...

Rory McIlroy believes it will be difficult for Ian Poulter or Lee Westwood to be a future Ryder Cup captain because they no ...

The Health Resources and Services Administration threatened Johnson & Johnson with fines and exclusion from the 340B Drug ...

Patient education could help clarify that remission in inflammatory bowel disease does not solely consist of resolved symptoms.